FIGS (FIGS) Q2 2026: International Revenue Jumps 67% as Brand Expansion Accelerates
FIGS delivered a breakout quarter with broad-based growth and a striking acceleration in international markets, underpinned by resilient demand from healthcare professionals and expanding product lines. Margin gains and a significant buyback authorization reinforce confidence, even as supply chain headwinds test operational agility. Forward visibility is rising, with management raising full-year targets and doubling down on strategic investments.
Summary
- International Expansion Surges: Overseas markets delivered standout growth, signaling growing global brand resonance.
- Product Diversification Accelerates: Non-scrubware and accessories are gaining traction, broadening wallet share and engagement.
- Operational Flexibility Proves Out: Supply chain disruption was swiftly mitigated, allowing upward guidance revision.
Business Overview
FIGS is a direct-to-consumer healthcare apparel company that designs and sells premium medical scrubs and related products primarily to healthcare professionals. The business is built on a replenishment-driven, non-discretionary model, with revenue generated through online channels, physical retail “community hubs,” teams (institutional sales), and international markets. The core business remains scrubwear, but FIGS is rapidly expanding into non-scrub apparel, accessories, and personalization through jewelry and pins.
Performance Analysis
FIGS posted 29% net revenue growth for Q2, with top-line acceleration driven by both core and emerging categories. Active customer count rose 13% to 3.1 million, while average order value (AOV) hit a record $127, reflecting both price action and improved sales mix. Net revenue per active customer reached an all-time high, surpassing even pandemic-era peaks, underscoring both higher spend and frequency.
International revenue growth of 67% stands out, now representing nearly 20% of total sales, while U.S. growth remains robust at 22%. Non-scrubware (outerwear, underscrubs, accessories) surged 40%, now accounting for almost a fifth of revenue, and is positioned for further mix shift. Margin expansion was notable: adjusted EBITDA margin (excluding one-time tariff refunds) reached 18.6%, reflecting higher full-price sell-through, lower returns, and operating leverage. The company also announced a new $100 million share buyback, signaling capital allocation confidence.
- International Outperformance: Europe, Latin America, and Canada drove outsized gains, with local marketing and ambassador programs fueling adoption.
- Resilient Core, Expanding Adjacencies: Scrubwear still comprises 82% of sales, but non-scrub and accessories are gaining share.
- Margin Expansion: Margin gains were powered by improved pricing, lower discounts, and operating efficiency, offsetting supply chain costs.
Despite a temporary supply chain disruption from a key Jordanian supplier, FIGS raised both top and bottom line guidance, highlighting operational resilience and demand visibility.
Executive Commentary
"Our growth is coming from across our business rather than from just one part of it. We are seeing tremendous traction across the board, our channels, product categories, geographies, and customer cohorts, driving a number of record highs for the brand."
Trina Spear, Co-founder and Chief Executive Officer
"Virtually all parts of our business are growing at strong rates as we look across categories, geographies, and channels. We saw highly productive launch events and promotions during the period, and continue to be incredibly encouraged by how we are performing during those business as usual selling days without specific brand activations."
Sarah Oughtred, Chief Financial Officer
Strategic Positioning
1. Global Brand Penetration
International markets are now a major growth engine, with 67% YoY growth and 27 new countries entered year-to-date. FIGS is deploying a “go broad and go deep” strategy: top-of-funnel brand campaigns in core markets like Canada, UK, and Mexico, while testing lower-funnel ambassador and digital programs in emerging regions. Early traction in high-potential markets (China, Japan, South Korea) is driving incremental investment and localization.
2. Product Ecosystem Expansion
FIGS is methodically building a “layering system” for healthcare professionals, expanding beyond scrubs into outerwear, underscrubs, lab coats, and now accessories. The V Coterie acquisition, though financially immaterial, unlocks a new emotional and functional category—personalized pins and jewelry—which strengthens brand loyalty and increases wallet share. Non-scrubware’s 40% growth affirms product adjacency potential.
3. Institutional and Retail Channel Growth
Teams (institutional sales) and Community Hubs (retail stores) both hit record revenues. Institutional wins like Bupa Dental Care validate the teams model, while new store leases signal a step-up in physical retail, with expansion planned in major healthcare hubs. Both channels deepen engagement and drive multi-touchpoint brand experience.
4. Supply Chain Agility and Risk Management
FIGS’ high-volume, low-SKU model enables rapid supplier reallocation. The recent disruption from a Jordanian partner was mitigated by leveraging other suppliers and expediting production, with minimal impact to inventory or in-stock levels. Air freight and inventory management are actively used to maintain service levels, while tariff refunds provided a one-time margin boost.
5. Brand Advocacy and Community Integration
FIGS continues to invest in community-driven marketing—advocacy events, collaborations (Star Wars, Spider-Man), and healthcare professional retreats. Storytelling and cultural resonance are core to the brand moat, with social engagement and word-of-mouth driving organic customer acquisition.
Key Considerations
This quarter marks a decisive inflection in both growth and profitability, but the path forward is shaped by several strategic levers and emerging risks.
Key Considerations:
- International Scale-Up: Global expansion is accelerating, but requires sustained investment in localization, logistics, and compliance.
- Non-Scrubware Margin Dilution: As accessories and outerwear grow, mix shift may pressure gross margins, though SG&A leverage offers offset.
- Supply Chain Complexity: Ongoing geopolitical and regulatory disruptions (e.g., Jordan) test operational flexibility and may increase freight costs.
- Brand-Driven Growth: Community engagement and storytelling are fueling organic growth, but require continued creative investment to maintain momentum.
- Capital Allocation Discipline: The $100 million buyback signals confidence, but must be balanced against the need for reinvestment in growth drivers.
Risks
Supply chain disruptions, particularly with key partners in volatile regions, remain a persistent risk, potentially impacting inventory availability and cost structure. As FIGS increases its international footprint, compliance, localization, and competitive pressures will intensify. The margin profile may face headwinds from mix shift toward lower-margin non-scrubware and higher freight costs. While brand momentum is strong, sustaining engagement and differentiation in a crowded marketplace requires ongoing creative and operational agility.
Forward Outlook
For Q3 2026, FIGS guided to:
- ~20% net revenue growth YoY
- Adjusted EBITDA margin of approximately 14%
For full-year 2026, management raised guidance:
- ~20% net revenue growth (up from prior 14%-16%)
- Operating margin of ~10.8%
- Adjusted EBITDA margin of 14.8%-15%
Management highlighted:
- Tariff refunds will continue to benefit margins in the back half, but air freight and supply chain adjustments will partially offset gains.
- International, teams, and retail hubs are expected to be the largest incremental growth drivers in 2027 and beyond.
Takeaways
FIGS is executing a multidimensional growth strategy with clear momentum across geographies, categories, and channels.
- International and Product Diversification: Overseas markets and non-scrubware are now material contributors, broadening the addressable market and deepening customer engagement.
- Operational Resilience: The company’s ability to navigate supply chain shocks while raising guidance demonstrates a robust and adaptable business model.
- Future Watchpoints: Investors should monitor international ramp, gross margin trends as mix shifts, and the scaling of teams and retail channels for sustained growth.
Conclusion
FIGS’ Q2 results reflect a business firing on multiple cylinders—geographic expansion, product innovation, and operational execution—while maintaining financial discipline. The company is well-positioned to leverage healthcare macro tailwinds and its unique brand platform, but must carefully manage supply chain and margin dynamics as growth accelerates.
Industry Read-Through
FIGS’ performance underscores the strength of replenishment-driven, non-discretionary apparel models in sectors with durable demand, such as healthcare. The success of international expansion and product adjacencies signals that category creators who own the end-user relationship can unlock substantial TAM beyond legacy categories. The supply chain agility on display is instructive for other specialty retailers facing geopolitical risk. Finally, FIGS’ focus on brand advocacy and community integration highlights a pathway for apparel brands to build defensible moats beyond product alone, especially in verticals where word-of-mouth and social proof drive organic growth.